Search Criteria
Scheme Search
Microbiology
Specimens
3 simulated swab/urine samples, 2 mL.
Examinations
Detection of C. trachomatis and N. gonorrhoeae nucleic acid.
Important Notes
See also scheme 5302 Sexually transmitted diseases multiplex, nucleic acid detection. The samples contain hDNA.
Microbiology
Specimens
2 lyophilised mixtures of bacteria
Examinations
C. difficile direct nucleic acid detection. Hypervirulent C. difficile strains also included
Important Notes
5200 includes also this examination. Four rounds per year.
Microbiology
Specimens
5 samples simulating plasma, 1.5 mL
Examinations
CMV and EBV NAT (quantitative).
Important Notes
Quantitative result processing.
Multiplex
Specimens
3 samples. Either lyophilised mixtures of bacteria and/or simulated samples, 1 mL.
Examinations
Direct nucleic acid detection. Pathogens included are Aeromonas, Campylobacter, E. coli EHEC (stx1/stx2), E. coli EAEC, E. coli EIEC, E. coli EPEC, E. coli ETEC, Plesiomonas, Salmonella, Shigella and Yersinia.
Important Notes
During the period of one calendar year, a comprehensive selection of listed pathogens will be covered.
Multiplex
Specimens
3 lyophilised samples.
Examinations
Nucleic acid detection of Cryptosporidium, Dientamoeba fragilis, Entamoeba histolytica and Giardia lamblia.
Important Notes
Microbiology
Specimens
3 lyophilsed or liquid plasma samples, 1.2 mL
Examinations
HBV DNA, quantitative and/or qualitative nucleic acid detection
Important Notes
Microbiology
Specimens
3 lyophilised or liquid plasma samples, 1.2 mL
Examinations
HCV RNA, quantitative and/or qualitative nucleic acid detection
Important Notes
Microbiology
Specimens
3 lyophilised or liquid plasma samples, 1.2 mL
Examinations
HIV-1 RNA, quantitative and/or qualitative nucleic acid detection
Important Notes
Microbiology
Specimens
2 simulated samples, 1 mL
Examinations
High-risk human papillomavirus NAT (hrHPVNAT). HPV genotypes included are: 16, 18, 31, 33, 39, 45, 51, 52, 66, 67
Important Notes
Suitable for nucleic acid methods used in cervical cancer screening. The samples contain hDNA. Four rounds per year.
Microbiology
Specimens
3 simulated liquid samples, 1 mL
Examinations
InfANAT, InfBNAT, RSVNAT
Important Notes
See also scheme 5300 Respiratory infections multiplex, nucleic acid detection or 5562 Multiple respiratory virus, nucleic acid detection. The samples contain hDNA. Two rounds per year.
Microbiology
Specimens
3 whole blood samples. The scheme contains primarily Plasmodium falciparum positive and negative samples, occasionally other Plasmodium species are included.
Examinations
Antigen and nucleic acid detection. Target antigens: HRP2 and/or pLDH and/or aldolase.
Important Notes
For clinical laboratories and POCT sites.
Multiplex
Specimens
3 simulated samples, 1 mL.
Examinations
Direct multiplex nucleic acid detection. Pathogens included are Escherichia coli K1, Haemophilus influenzae, Listeria monocytogenes, Neisseria meningitidis, Streptococcus agalactiae, Streptococcus pneumoniae, Cytomegalovirus (CMV), Enterovirus, Epstein-Barr virus (EBV), Herpes simplex virus 1 (HSV1), Herpes simplex virus 2 (HSV2), Human herpesvirus 6 (HHV6), Human parechovirus (HPeV), Varizella zoster virus (VZV) Cryptococcus neoformans and Cryptococcus gattii.
Important Notes
During the period of one calendar year, a comprehensive selection of listed pathogens will be covered.